1-4 of 4
acquired factor viii deficiency
Close
Sort by
Journal Articles

Strong Correlation of High Endogenous Plasma Levels of Tissue Factor Pathway Inhibitor (TFPI) with Poor Blood Clotting and Corrective Action of BAX 513 Under FVIII-Inhibited Conditions

Michael Dockal, PhD, Monika Gorczyca, PhD, Sabine Knappe, PhD, Michael Palige, PhD, Hartmut J. Ehrlich, MD, Friedrich Scheiflinger, PhD, Bernd Jilma, MD
Journal: Blood
Blood (2011) 118 (21): 1201.
https://doi.org/10.1182/blood.V118.21.1201.1201
Published: 2011
Journal Articles

Durable Responses to Rituximab In Acquired Factor VIII Deficiency.

Abha Goyal, Iyad S. Hamarneh, Mark W. Karwal, Steven R. Lentz
Journal: Blood
Blood (2010) 116 (21): 3680.
https://doi.org/10.1182/blood.V116.21.3680.3680
Published: 2010
Journal Articles

A Canadian Prospective, Observational, Open-Label, Pharmacovigilance Study to Assess the Safety of Humate-P ® Injection Volume Reduced (ivr) in Patients with Von Willebrand Disease.

Alan Tinmouth, MD, FRCPC, Victor S. Blanchette, Ramachandran Devaraj, Bruce Ritchie, David Barnes, Gigi van den Hoef
Journal: Blood
Blood (2009) 114 (22): 4190.
https://doi.org/10.1182/blood.V114.22.4190.4190
Published: 2009
Journal Articles

Rituximab in the Treatment of Factor VIII Inhibitor.

Mercedes Maruscak, MSN, FNP, Barry Cohan, MD, Linda Aghakhanian, PA-C, Kalust Ucar, MD
Journal: Blood
Blood (2005) 106 (11): 4064.
https://doi.org/10.1182/blood.V106.11.4064.4064
Published: 2005